Journal
JOURNAL OF CLINICAL MEDICINE
Volume 6, Issue 2, Pages -Publisher
MDPI
DOI: 10.3390/jcm6020021
Keywords
COPD; oxidative stress; neutrophil; macrophage; antioxidant; antiproteinase; mechanisms; therapeutic studies
Categories
Funding
- Medical Research Council
- MRC [MR/L008335/1] Funding Source: UKRI
- Academy of Medical Sciences (AMS) [AMS-SGCL5-Sapey] Funding Source: researchfish
- British Lung Foundation [LT12-8] Funding Source: researchfish
- Medical Research Council [MR/L008335/1] Funding Source: researchfish
Ask authors/readers for more resources
Markers of oxidative stress are increased in chronic obstructive pulmonary disease (COPD) and reactive oxygen species (ROS) are able to alter biological molecules, signaling pathways and antioxidant molecule function, many of which have been implicated in the pathogenesis of COPD. However, the involvement of ROS in the development and progression of COPD is not proven. Here, we discuss the sources of ROS, and the defences that have evolved to protect against their harmful effects. We address the role that ROS may have in the development and progression of COPD, as well as current therapeutic attempts at limiting the damage they cause. Evidence has indicated that the function of several key cells appears altered in COPD patients, and expression levels of important oxidant and antioxidant molecules may be abnormal. Therapeutic trials attempting to restore equilibrium to these molecules have not impacted upon all facets of disease and whilst the theory behind ROS influence in COPD appears sound, current models testing relevant pathways to tissue damage are limited. The heterogeneity seen in COPD patients presents a challenge to our understanding, and further research is essential to identify potential targets and stratified COPD patient populations where ROS therapies may be maximally efficacious.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available